Servier, an international pharmaceutical company, and Yposkesi, a CDMO for gene therapy viral vector manufacturing, have signed a manufacturing service agreement under which Yposkesi has been selected to develop and GMP manufacture lentiviral vectors to support allogenic CAR-T cell technology development. Servier will have access to Yposkesi’s know-how and technology for manufacturing lentiviral vectors, as well as its analytical development and quality assessment resources and capacity. Ypos...